Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation

2013 ◽  
Vol 9 (R) ◽  
pp. R127-R135 ◽  
Author(s):  
Dagmara Hering ◽  
Murray D. Esler ◽  
Markus P. Schlaich
2013 ◽  
Vol 8 (3) ◽  
pp. 197-205 ◽  
Author(s):  
Dimitrios Petras ◽  
Konstantinos Koutroutsos ◽  
Athanasios Kordalis ◽  
Costas Tsioufis ◽  
Christodoulos Stefanadis

2018 ◽  
Vol 61 (2) ◽  
pp. 261-274 ◽  
Author(s):  
Emma R. Lyons ◽  
Jessica Norman Wells ◽  
Carolyn M. Scholtes ◽  
Brianna Mintz ◽  
Ryan J. Giuliano ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Jeanie Park

Patients with chronic kidney disease are at significantly increased risk for cardiovascular disease and sudden cardiac death. One mechanism underlying increased cardiovascular risk in patients with renal failure includes overactivation of the sympathetic nervous system (SNS). Multiple human and animal studies have shown that central sympathetic outflow is chronically elevated in patients with both end-stage renal disease (ESRD) and chronic kidney disease (CKD). SNS overactivation, in turn, increases the risk of cardiovascular disease and sudden death by increasing arterial blood pressure, arrythmogenicity, left ventricular hypertrophy, and coronary vasoconstriction and contributes to the progression renal disease. This paper will examine the evidence for SNS overactivation in renal failure from both human and experimental studies and discuss mechanisms of SNS overactivity in CKD and therapeutic implications.


Sign in / Sign up

Export Citation Format

Share Document